Evidence map›Paper›PMID 26041600›Full record

Trial reportCirculation. Heart failure2015

Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).

Anuradha Lala, Steven E McNulty, Robert J Mentz, Shannon M Dunlay, Justin M Vader, Omar F AbouEzzeddine, Adam D DeVore, Prateeti Khazanie, Margaret M Redfield, Steven R Goldsmith and 5 more

6 registry-linked trialsOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Circulation. Heart failure, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 145 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 6 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04298229 phase3completedstarted 2020, after this paper: background citation

A Randomized, Open-label Study of Dapagliflozin in Patients With or Without Type 2 Diabetes Admitted With Acute Heart Failure

Ran2020Enrolled240Registered outcomes3Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Heart FailureArmsDapagliflozin 10 mg, Protocolized Diuretic Therapy
Open the trial in the graph
NCT00577135 phase3completednot on this map

Diuretic Optimal Strategy Evaluation in Acute Heart Failure (The DOSE-AHF Study)

TypeinterventionalSponsorDuke UniversityRan2008 to 2010Enrolled308ConditionsHeart FailureArmsFurosemide-Q12 hour bolus, Furosemide-Continuous Infusion, Furosemide-Low Intensification, Furosemide-High Intensification
NCT00608491 phase3completednot on this map

CARdiorenal REScue Study in Acute Decompensated Heart Failure: CARRESS

TypeinterventionalSponsorDuke UniversityRan2008 to 2012Enrolled188ConditionsHeart FailureArmsStepped pharmacologic care, Ultrafiltration
NCT02638142 recruitingnot on this map

Continuous Versus Bolus Intermittent Loop Diuretic Infusion in Acutely Decompensated Heart Failure: Evaluation of Renal Function, Congestion Signs, BNP and Outcome

TypeobservationalSponsorUniversity of SienaRan2015 to 2028Enrolled370ConditionsAcute Heart FailureArmsContinuous Furosemide Infusion, Intermittent Furosemide Infusion
NCT04305717 narecruitingnot on this mapstarted 2020, after this paper: background citation

Remote Dielectric Sensing (ReDS) for a SAFE Discharge in Patients With Acutely Decompensated Heart Failure: The ReDS-SAFE HF Study

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2020 to 2021Enrolled240ConditionsHeart Failure, Lung CongestionArmsReDS-guided strategy
NCT06921603 narecruitingnot on this mapstarted 2025, after this paper: background citation

Point-of-Care Ultrasound-Guided Diuresis for Acute Decompensated Heart Failure to Reduce 30-Day Readmissions and Acute Kidney Injury

TypeinterventionalSponsorUniversity of PittsburghRan2025 to 2026Enrolled588ConditionsHeart Decompensation, Acute, Acute Kidney InjuriesArmsFurosemide (Standard Diuretic) Treatment, POCUS-Assessed Diuretic Management
3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 6 syntheses or guidelines pooled it, 321 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Anuradha LalaFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.). anu.lala@mountsinai.org.
Steven E McNultyFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Robert J MentzFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Shannon M DunlayFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Justin M VaderFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Omar F AbouEzzeddineFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Adam D DeVoreFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Prateeti KhazanieFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Margaret M RedfieldFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Steven R GoldsmithFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Bradley A BartFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Kevin J AnstromFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
G Michael FelkerFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Adrian F HernandezFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Lynne W StevensonFrom the Division of Cardiology, Brigham and Women's Hospital, Boston, MA (A.L., L.W.S.); The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (A.L.); Duke Clinical Research Institute, Durham, NC (S.E.M., R.J.M., A.D.D., P.K., K.J.A., G.M.F., A.F.H.); Mayo Clinic, Rochester, MN (S.M.D., O.F.A., M.M.R.); Washington University School of Medicine, St Louis, MO (J.M.V.); and Hennepin County Medical Center, Minneapolis, MN (S.R.G., B.A.B.).
Cardiovascular Institute of the South · USMayo Clinic in Arizona · USIcahn School of Medicine at Mount Sinai · USBrigham and Women's Hospital · USWashington University in St. Louis · US

Funding

Mayo Heart Failure Regional Clinical CenterU10HL110262 · NHLBI · MAYO CLINIC ROCHESTER · PI REDFIELD, MARGARET M · 2012 to 2018
$3.6M
Heart Failure Clinical Research Network Regional Clinical Center (U10)U10HL110312 · NHLBI · DUKE UNIVERSITY · PI FELKER, GARY M · 2012 to 2018
$3.5M
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)U10HL110309 · NHLBI · WASHINGTON UNIVERSITY · PI DAVILA-ROMAN, VICTOR G., MANN, DOUGLAS L · 2012 to 2018
$3.5M
Harvard Regional Clinical Center of the NHLBI Heart Failure NetworkU10HL110337 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI GIVERTZ, MICHAEL M, LEWIS, GREGORY DYER · 2012 to 2018
$3.5M
Partners Heart Failure NetworkU01HL084877 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENSON, LYNNE W · 2006 to 2011
$2.9M
Heart Failure Clinical Trials NetworkU10HL110302 · NHLBI · EMORY UNIVERSITY · PI SMITH, ANDREW · 2012 to 2018
$2.5M
NHLBI NIH HHS U01 HL084877NHLBI NIH HHS U10 HL110262NHLBI NIH HHS U10 HL110302NHLBI NIH HHS U10 HL110309NHLBI NIH HHS U10 HL110312NHLBI NIH HHS U10 HL110337NHLBI NIH HHS U10HL110337
6 · The paper itself

Abstract

backgroundCongestion is the most frequent cause for hospitalization in acute decompensated heart failure. Although decongestion is a major goal of acute therapy, it is unclear how the clinical components of congestion (eg, peripheral edema, orthopnea) contribute to outcomes after discharge or how well decongestion is maintained. METHODS AND

resultsA post hoc analysis was performed of 496 patients enrolled in the Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARRESS-HF) trials during hospitalization with acute decompensated heart failure and clinical congestion. A simple orthodema congestion score was generated based on symptoms of orthopnea (≥2 pillows=2 points, <2 pillows=0 points) and peripheral edema (trace=0 points, moderate=1 point, severe=2 points) at baseline, discharge, and 60-day follow-up. Orthodema scores were classified as absent (score of 0), low-grade (score of 1-2), and high-grade (score of 3-4), and the association with death, rehospitalization, or unscheduled medical visits through 60 days was assessed. At baseline, 65% of patients had high-grade orthodema and 35% had low-grade orthodema. At discharge, 52% patients were free from orthodema at discharge (score=0) and these patients had lower 60-day rates of death, rehospitalization, or unscheduled visits (50%) compared with those with low-grade or high-grade orthodema (52% and 68%, respectively; P=0.038). Of the patients without orthodema at discharge, 27% relapsed to low-grade orthodema and 38% to high-grade orthodema at 60-day follow-up.

conclusionsIncreased severity of congestion by a simple orthodema assessment is associated with increased morbidity and mortality. Despite intent to relieve congestion, current therapy often fails to relieve orthodema during hospitalization or to prevent recurrence after discharge. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifiers: NCT00608491, NCT00577135.

Indexed as

HospitalizationAcute DiseaseAgedAged, 80 and overDiureticsDyspneaEdemaFemaleHeart FailureHumansMaleMiddle AgedPatient DischargePatient ReadmissionPredictive Value of TestsRecurrenceDiureticsdyspneaedemafollow-up studiesheart failurehospitalization

Identifiers

PMID26041600
PMCPMC4512849
OpenAlexW2548855492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.